Clinical Trial Update: Maxi-Analgesic Phase 2 Study to Compare the Analgesic Effects in Different Dosing Groups to Treat Teeth Extraction Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Maxi-Analgesic for dental extraction pain in different dosing groups has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Pain

Drugs mentioned

• Maxi-Analgesic

Snippet

Sponsor: AFT Pharmaceuticals, Ltd. | Conditions: Dental Pain | Phase 2 | Status: WITHDRAWN